Literature DB >> 10764946

The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF).

E Y Huang1, J Y Li, P P Tan, C H Wong, J C Chen.   

Abstract

Neuropeptide FF (NPFF), an endogenous opioid-related neuromodulater, has been reported to show significant effects on the cardiovascular system, namely elevation of arterial blood pressure (BP) and heart rate (HR) in rats. In the present study, we synthesized two novel NPFF analogs, PFRFamide (putative NPFF agonist) and PFR(Tic)amide (putative NPFF antagonist), and examined their cardiovascular effect on BP and HR in anesthetized rats. The arterial mean BP and HR were measured by way of direct femoral artery catheterization. The data showed that PFRFamide increased BP in a dose-dependent manner, while PFR(Tic)amide decreased BP dose-dependently. These results revealed the possibility of PFRFamide and PFR(Tic)amide to be NPFF agonist and antagonist (or inverse agonist), respectively. These two NPFF analogs may possess potential in new drug design, and the NPFF system could be very important in mammalian cardiovascular function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764946     DOI: 10.1016/s0196-9781(99)00189-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  2 in total

1.  Selective mode of action of guanidine-containing non-peptides at human NPFF receptors.

Authors:  Maria Findeisen; Cäcilia Würker; Daniel Rathmann; René Meier; Jens Meiler; Roger Olsson; Annette G Beck-Sickinger
Journal:  J Med Chem       Date:  2012-06-26       Impact factor: 7.446

2.  Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors' Activation.

Authors:  Piotr Wojciechowski; Kryspin Andrzejewski; Katarzyna Kaczyńska
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.